Affiliation:
1. Department of Dental Anesthesiology, Faculty of Dental Medicine and Graduate School of Dental Medicine, Hokkaido University, Sapporo, Japan
Abstract
Angiotensin receptor blockers (ARBs) are commonly used to treat hypertension. However, similar to angiotensin-converting enzyme inhibitors, ARBs can also cause refractory hypotension during general anesthesia. Therefore, it has been recommended that ARBs be withheld for 24 hours prior to the induction of anesthesia. This is a case report of refractory hypotension requiring the administration of potent vasopressors after the induction of general anesthesia despite withholding telmisartan for 24 hours. In the same patient undergoing a subsequent general anesthetic, telmisartan was withheld for 5 days before induction, leading to mild intraoperative hypotension that responded adequately to phenylephrine. The primary cause of refractory hypotension during the first general anesthetic was suspected to be an insufficient telmisartan washout period. Telmisartan's half-life of 24 hours is notably the longest of all ARBs in current use. This case report demonstrates that refractory hypotension during general anesthesia cannot always be avoided by withholding telmisartan for 24 hours before the induction of anesthesia. Therefore, a washout period greater than 24 hours is preferable for patients taking telmisartan.
Publisher
American Dental Society of Anesthesiology (ADSA)
Subject
Anesthesiology and Pain Medicine
Reference13 articles.
1. Bertrand
M,
Godet
G,
Meersschaert
K,
Brun
L,
Salcedo
E,
Coriat
P.
Should the angiotensin II antagonists be discontinued before surgery?
Anesth Analg
.
2001;92:26–30.
2. Brabant
SM,
Bertrand
M,
Eyraud
D,
Darmon
PL,
Coriat
P.
The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists.
Anesth Analg.
1999;89:1388–1392.
3. Nabbi
R,
Woehlck
HJ,
Riess
ML.
Refractory hypotension during general anesthesia despite preoperative discontinuation of an angiotensin receptor blocker.
F1000Res.
2013;2:12.
4. Roshanov
PS,
Rochwerg
B,
Patel
A,
et al.
Withholding versus continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers before noncardiac surgery: an analysis of the vascular events in noncardiac surgery patients cohort evaluation prospective cohort.
Anesthesiology.
2017;126:16–27.
5. Hollmann
C,
Fernandes
NL,
Biccard
BM.
A systematic review of outcomes associated with withholding or continuing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers before noncardiac surgery.
Anesth Analg.
2018;127:678–687.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献